{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:34:17Z","timestamp":1781883257624,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25090053"],"award-info":[{"award-number":["25090053"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H04706"],"award-info":[{"award-number":["16H04706"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K19628"],"award-info":[{"award-number":["17K19628"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AMED PRIME"},{"name":"Aichi Cancer Research Foundation, Takeda Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41388-018-0417-7","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T04:43:49Z","timestamp":1541479429000},"page":"1966-1978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation"],"prefix":"10.1038","volume":"38","author":[{"given":"Akihiro","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruaki","family":"Fujishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Mishiro-Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Sekido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"417_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrc.2017.42","volume":"17","author":"TA Yap","year":"2017","unstructured":"Yap TA, Aerts JG, Popat S, Fennell DA. Novel insights into mesothelioma biology and implications for therapy. Nat Rev Cancer. 2017;17:475\u201388.","journal-title":"Nat Rev Cancer"},{"key":"417_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.aogh.2014.09.016","volume":"80","author":"AL Frank","year":"2014","unstructured":"Frank AL, Joshi TK. The global spread of asbestos. Ann Glob Health. 2014;80:257\u201362.","journal-title":"Ann Glob Health"},{"key":"417_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591\u2013603.","journal-title":"N Engl J Med"},{"key":"417_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11864-017-0488-7","volume":"18","author":"MMJ Disselhorst","year":"2017","unstructured":"Disselhorst MMJ, Burgers SJA, Baas P. Optimal therapy of advanced stage mesothelioma. Curr Treat Options Oncol. 2017;18:48.","journal-title":"Curr Treat Options Oncol"},{"key":"417_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1183\/16000617.0063-2016","volume":"25","author":"AC Bibby","year":"2016","unstructured":"Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev.. 2016;25:472\u201386.","journal-title":"Eur Respir Rev."},{"key":"417_CR6","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","volume":"35","author":"DB Nelson","year":"2017","unstructured":"Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, et al. Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis. J Clin Oncol. 2017;35:3354\u201362.","journal-title":"J Clin Oncol"},{"key":"417_CR7","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","volume":"92","author":"AB Bianchi","year":"1995","unstructured":"Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, et al. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA. 1995;92:10854\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"417_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48:407\u201316.","journal-title":"Nat Genet"},{"key":"417_CR9","first-page":"1227","volume":"55","author":"Y Sekido","year":"1995","unstructured":"Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, et al. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res. 1995;55:1227\u201331.","journal-title":"Cancer Res"},{"key":"417_CR10","first-page":"75","volume":"3","author":"E Felley-Bosco","year":"2014","unstructured":"Felley-Bosco E, Stahel R. Hippo\/YAP pathway for targeted therapy. Transl Lung Cancer Res. 2014;3:75\u201383.","journal-title":"Transl Lung Cancer Res"},{"key":"417_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","volume":"34","author":"Y Sekido","year":"2013","unstructured":"Sekido Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 2013;34:1413\u20139.","journal-title":"Carcinogenesis"},{"key":"417_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163:811\u201328.","journal-title":"Cell"},{"key":"417_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246\u201357.","journal-title":"Nat Rev Cancer"},{"key":"417_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/0008-5472.CAN-10-2164","volume":"71","author":"H Murakami","year":"2011","unstructured":"Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, et al. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011;71:873\u201383.","journal-title":"Cancer Res"},{"key":"417_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/onc.2013.528","volume":"34","author":"I Tanaka","year":"2015","unstructured":"Tanaka I, Osada H, Fujii M, Fukatsu A, Hida T, Horio Y, et al. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade. Oncogene. 2015;34:73\u201383.","journal-title":"Oncogene"},{"key":"417_CR16","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1158\/1078-0432.CCR-16-1971","volume":"23","author":"R Tranchant","year":"2017","unstructured":"Tranchant R, Quetel L, Tallet A, Meiller C, Renier A, de Koning L, et al. Co-occurring mutations of tumor suppressor genes, LATS2 and NF2, in malignant pleural mesothelioma. Clin Cancer Res. 2017;23:3191\u2013202.","journal-title":"Clin Cancer Res"},{"key":"417_CR17","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/carcin\/bgn200","volume":"29","author":"T Yokoyama","year":"2008","unstructured":"Yokoyama T, Osada H, Murakami H, Tatematsu Y, Taniguchi T, Kondo Y, et al. YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation. Carcinogenesis. 2008;29:2139\u201346.","journal-title":"Carcinogenesis"},{"key":"417_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20111653","volume":"209","author":"M Fujii","year":"2012","unstructured":"Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, et al. TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med. 2012;209:479\u201394.","journal-title":"J Exp Med"},{"key":"417_CR19","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1038\/onc.2012.5","volume":"31","author":"T Mizuno","year":"2012","unstructured":"Mizuno T, Murakami H, Fujii M, Ishiguro F, Tanaka I, Kondo Y, et al. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. Oncogene. 2012;31:5117\u201322.","journal-title":"Oncogene"},{"key":"417_CR20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/carcin\/bgw084","volume":"37","author":"T Kakiuchi","year":"2016","unstructured":"Kakiuchi T, Takahara T, Kasugai Y, Arita K, Yoshida N, Karube K, et al. Modeling mesothelioma utilizing human mesothelial cells reveals involvement of phospholipase-C beta 4 in YAP-active mesothelioma cell proliferation. Carcinogenesis. 2016;37:1098\u2013109.","journal-title":"Carcinogenesis"},{"key":"417_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tcb.2015.05.002","volume":"25","author":"CG Hansen","year":"2015","unstructured":"Hansen CG, Moroishi T, Guan KL. YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol. 2015;25:499\u2013513.","journal-title":"Trends Cell Biol"},{"key":"417_CR22","doi-asserted-by":"publisher","first-page":"26245","DOI":"10.1074\/jbc.M112.382036","volume":"287","author":"W Huang","year":"2012","unstructured":"Huang W, Lv X, Liu C, Zha Z, Zhang H, Jiang Y, et al. The N-terminal phosphodegron targets TAZ\/WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem. 2012;287:26245\u201353.","journal-title":"J Biol Chem"},{"key":"417_CR23","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1128\/MCB.00254-07","volume":"27","author":"Y Tian","year":"2007","unstructured":"Tian Y, Kolb R, Hong JH, Carroll J, Li D, You J, et al. TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol Cell Biol. 2007;27:6383\u201395.","journal-title":"Mol Cell Biol"},{"key":"417_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the Roots of Cancer. Cancer Cell. 2016;29:783\u2013803.","journal-title":"Cancer Cell"},{"key":"417_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15:73\u201379.","journal-title":"Nat Rev Cancer"},{"key":"417_CR26","doi-asserted-by":"publisher","first-page":"D354","DOI":"10.1093\/nar\/gkj102","volume":"34","author":"M Kanehisa","year":"2006","unstructured":"Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006;34:D354\u2013357.","journal-title":"Nucleic Acids Res"},{"key":"417_CR27","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/ijc.22006","volume":"119","author":"Y Adachi","year":"2006","unstructured":"Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel DT, Nishimoto N. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int J Cancer. 2006;119:1303\u201311.","journal-title":"Int J Cancer"},{"key":"417_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/1940-6207.CAPR-15-0347","volume":"9","author":"Y Kadariya","year":"2016","unstructured":"Kadariya Y, Menges CW, Talarchek J, Cai KQ, Klein-Szanto AJ, Pietrofesa RA, et al. Inflammation-related IL1beta\/IL1R signaling promotes the development of asbestos-induced malignant mesothelioma. Cancer Prev Res (Phila). 2016;9:406\u201314.","journal-title":"Cancer Prev Res (Phila)"},{"key":"417_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1743-6109.2006.00109.x","volume":"14","author":"S Stadlmann","year":"2006","unstructured":"Stadlmann S, Pollheimer J, Renner K, Zeimet AG, Offner FA, Amberger A. Response of human peritoneal mesothelial cells to inflammatory injury is regulated by interleukin-1beta and tumor necrosis factor-alpha. Wound Repair Regen. 2006;14:187\u201394.","journal-title":"Wound Repair Regen"},{"key":"417_CR30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3892\/ijo.25.4.993","volume":"25","author":"Y Wang","year":"2004","unstructured":"Wang Y, Faux SP, Hallden G, Kirn DH, Houghton CE, Lemoine NR, et al. Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite. Int J Oncol. 2004;25:173\u20138.","journal-title":"Int J Oncol"},{"key":"417_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-1-4471-6458-6_6","volume":"818","author":"ME Menezes","year":"2014","unstructured":"Menezes ME, Bhatia S, Bhoopathi P, Das SK, Emdad L, Dasgupta S, et al. MDA-7\/IL-24: multifunctional cancer killing cytokine. Adv Exp Med Biol. 2014;818:127\u201353.","journal-title":"Adv Exp Med Biol"},{"key":"417_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cytogfr.2012.08.004","volume":"23","author":"EL Whitaker","year":"2012","unstructured":"Whitaker EL, Filippov VA, Duerksen-Hughes PJ. Interleukin 24: mechanisms and therapeutic potential of an anti-cancer gene. Cytokine Growth Factor Rev. 2012;23:323\u201331.","journal-title":"Cytokine Growth Factor Rev"},{"key":"417_CR33","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1110955","volume":"309","author":"JH Hong","year":"2005","unstructured":"Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005;309:1074\u20138.","journal-title":"Science"},{"key":"417_CR34","doi-asserted-by":"publisher","first-page":"14347","DOI":"10.1074\/jbc.M901568200","volume":"284","author":"SW Chan","year":"2009","unstructured":"Chan SW, Lim CJ, Loo LS, Chong YF, Huang C, Hong W. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J Biol Chem. 2009;284:14347\u201358.","journal-title":"J Biol Chem"},{"key":"417_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/BJ20041434","volume":"388","author":"WM Mahoney Jr.","year":"2005","unstructured":"Mahoney WM Jr., Hong JH, Yaffe MB, Farrance IK. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J. 2005;388:217\u201325.","journal-title":"Biochem J"},{"key":"417_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1748","volume":"10","author":"X Varelas","year":"2008","unstructured":"Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol. 2008;10:837\u201348.","journal-title":"Nat Cell Biol"},{"key":"417_CR37","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1158\/0008-5472.CAN-07-2696","volume":"68","author":"SW Chan","year":"2008","unstructured":"Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 2008;68:2592\u20138.","journal-title":"Cancer Res"},{"key":"417_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759\u201372.","journal-title":"Cell"},{"key":"417_CR39","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1101\/gad.176800.111","volume":"25","author":"KP Bhat","year":"2011","unstructured":"Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011;25:2594\u2013609.","journal-title":"Genes Dev"},{"key":"417_CR40","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1128\/MCB.01346-13","volume":"34","author":"Z Yang","year":"2014","unstructured":"Yang Z, Nakagawa K, Sarkar A, Maruyama J, Iwasa H, Bao Y, et al. Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model. Mol Cell Biol. 2014;34:1607\u201321.","journal-title":"Mol Cell Biol"},{"key":"417_CR41","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0417-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:57:22Z","timestamp":1775260642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0417-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0417-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}